Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 11/29/11 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 Oppenheimer 22nd Annual Healthcare Conference in New York City on Tuesday, December 13, 2011 at 9:55AM EST.
A live webcast of the presentation will be available under the Webcast section of the Company's Website at
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ().
Joel A. Fernandes
Threshold Pharmaceuticals, Inc.
650.474.8273
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.11.2011 - 10:30 Uhr
Sprache: Deutsch
News-ID 91742
Anzahl Zeichen: 0
contact information:
Town:
SOUTH SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 236 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Threshold Pharmaceuticals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
